Summary & Overview
CPT 83010: Haptoglobin Measurement to Evaluate Hemolysis
CPT code 83010 represents the laboratory measurement of haptoglobin, a hemoglobin‑binding glycoprotein used clinically to assess hemolysis and certain causes of anemia. As a common clinical chemistry assay, this code is relevant across inpatient and outpatient settings where evaluation of red blood cell destruction is required. Nationally, haptoglobin testing supports diagnostic decision making, transfusion evaluation, and monitoring of hemolytic processes.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for ordering the test, typical sites of service, and the common use cases that drive utilization. The publication also summarizes payer coverage patterns and benchmarks where available, highlights relevant coding and claims considerations, and outlines policy or reimbursement updates that affect laboratory billing for this assay.
This summary is intended for laboratory administrators, billing staff, clinicians, and policy analysts seeking a national perspective on the role and handling of CPT code 83010 in clinical practice and payer interactions. Data not available in the input.
Billing Code Overview
CPT code 83010 reports a haptoglobin measurement performed by a laboratory analyst, typically on a serum specimen. Haptoglobin is a hemoglobin‑binding glycoprotein; measurement helps clinicians evaluate hemolysis, assess causes of anemia, and support diagnosis or monitoring of other conditions associated with red blood cell destruction.
Service type: Laboratory test — clinical chemistry / hematology
Typical site of service: Clinical laboratory or hospital laboratory; specimen collection may occur in outpatient clinics, physician offices, or inpatient settings
Clinical & Coding Specifications
Clinical Context
A 45-year-old adult presents to primary care with symptoms of fatigue, jaundice, and dark urine. The clinician documents anemia on CBC with elevated reticulocyte count and suspects hemolysis. A serum sample is ordered for haptoglobin testing to assess intravascular hemolysis. The patient has venous blood drawn in the outpatient phlebotomy area; the specimen is sent to the clinical laboratory. The lab analyst performs the quantitative haptoglobin assay (83010) and reports the result to the ordering provider. Results are reviewed during a follow-up visit or via the electronic health record, guiding additional testing such as direct antiglobulin testing, peripheral smear review, or referrals to hematology.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component from a separate provider for lab testing that reports interpretation distinct from technical processing. |
TC | Technical component | Use when billing only the technical component (laboratory processing) for the assay. |